HKEX Stock Code: 01093English|繁體|简体
Financial Summary
  For the year ended 31 December
  2015
RMB'000
(Restated)
(note)
2016
RMB'000
(Restated)
(note)
2017
RMB'000
(Restated)
(note)
2018
RMB'000
(Restated)
 
2019
RMB'000
 
 
Results          
Revenue 9,171,949 10,575,530 13,386,479 17,716,540 22,103,192
Cost of sales (4,969,143) (5,181,498) (5,303,764) (5,979,187) (6,192,211)
           
Gross profit 4,202,806 5,394,032 8,082,715 11,737,353 15,910,981
Other income 69,682 82,902 103,366 139,742 243,783
Other gains or losses (14,347) (6,904) (50,953) 155,195 48,450
Selling and distribution expenses (1,824,901) (2,383,877) (3,780,688) (6,184,505) (8,712,083)
Administrative expenses (421,877) (475,536) (555,581) (656,597) (748,509)
Research and development expenses (261,227) (344,685) (703,458) (1,342,101) (2,000,426)
Other expenses (6,142) (623) (79,083) (26,125) (142,015)
           
Operating profit 1,743,994 2,265,309 3,016,318 3,822,962 4,600,181
Finance costs (45,350) (35,663) (23,182) (74,337) (32,426)
Share of results of          
   — an associate 141
   — a joint venture 8,584 23,563 8,892 43,554 58,407
Loss on disposal of an associate (7,143)
           
Profit before tax 1,700,199 2,253,209 3,002,028 3,792,179 4,626,162
Income tax expense (348,101) (446,401) (594,252) (733,760) (892,810)
           
Profit for the year 1,352,098 1,806,808 2,407,776 3,058,419 3,733,352
           
Profit for the year attributable to:          
   Owners of the Company 1,340,542 1,796,226 2,399,484 3,080,802 3,714,106
   Non-controlling interests 11,556 10,582 8,292 (22,383) 19,246
           
  1,352,098 1,806,808 2,407,776 3,058,419 3,733,352
           
  RMB cents
(Restated)
RMB cents
(Restated)
RMB cents
(Restated)
RMB cents
(Restated)
RMB cents
Earnings per share          
   Basic 22.68 30.14 39.40 49.36 59.65
           
   Diluted 22.50 29.93 39.39 N/A 59.64



  As at 31 December
  2015
RMB'000
(Restated)
2016
RMB'000
(Restated)
2017
RMB'000
(Restated)
2018
RMB'000
(Restated)
2019
RMB'000
 
Assets and liabilities          
Total assets 11,346,395 13,210,366 17,988,805 23,216,837 26,318,322
Total liabilities (3,961,430) (4,089,133) (5,129,097) (7,687,237) (6,800,157)
         
Net assets 7,384,965 9,121,233 12,859,708 15,529,600 19,518,165
         
Equity attributable to owners of          
   the Company 7,322,490 9,046,325 12,788,655 15,052,260 18,461,723
Non-controlling interests 62,475 74,908 71,053 477,340 1,056,442
         
Total equity 7,384,965 9,121,233 12,859,708 15,529,600 19,518,165
Note: Other gains or losses and research and development expenses were reclassified from other income, administrative expense and other expenses in the consolidated financial statements so as to conform with the current year presentation.
© Copyright 2021 CSPC Pharmaceutical Group Limited. All Rights Reserved.